Abstract Myocyte Enhancer Factor 2 C (MEF2C), one of the transcription factors of the MADS-
BOX family, is involved in embryonic brain development, neuronal formation and …

Highlights•MEF2s control gene expression in the developing and adult brain.•MEF2s
regulate synaptic plasticity during critical periods of brain development.•Sensory …

Alternative splicing is widely acknowledged to be a crucial regulator of gene expression and
is a key contributor to both normal developmental processes and disease states. While cost …

Brain size and cognitive skills are the most dramatically changed traits in humans during
evolution and yet the genetic mechanisms underlying these human-specific changes remain …

Keratinocyte cancers (KC) are the most prevalent malignancies in fair‐skinned populations,
posing a significant medical and economic burden to health systems. KC originate in the …

Alzheimer's disease (AD) is a neurodegenerative disease characterized by amyloid plaques
and neurofibrillary tangles which significantly affects people's life quality. Recently, AD has …

Myocyte enhancer factor 2A (MEF2A) is a member of the myocyte enhancer factor 2 family.
MEF2A is widely distributed in various tissues and organs and participates in various …

Cell regulatory networks are the determinants of cellular homeostasis. Any alteration to
these networks results in the disturbance of cellular homeostasis and induces cells towards …

Major depressive disorder (MDD) is a prevalent, chronic, and relapse‐prone psychiatric
disease. However, the intermediate molecules resulting from stress and neurological …

The family of myocyte enhancer factor 2 (MEF2) transcription factors comprises four highly
conserved members that play an important role in the nervous system. They appear in …